News Archives

News Archives

Avivagen Announces Closing of Additional $1.75 Million Private Placement

Ottawa, ON /Business Wire/ January 27, 2020 / — Avivagen Inc. (TSXV:VIV) (“Avivagen” or the “Company”), a life sciences innovation company with a series of patent protected products that support and optimize human and animal health, is pleased to announce the successful second and final closing of its previously announced non-brokered private placement (the “Offering”).   …Read More

Mimi’s Rock Corp. and Avivagen Inc. Announce Launch of Dr Tobias Dog Chews on Amazon.com

TORONTO, Jan. 23, 2020 /CNW/ – Mimi’s Rock Corp. (TSXV:MIMI) and Avivagen Inc. (TSXV:VIV) (collectively “the Companies”) are pleased to announce the Dr Tobias Dog Chews containing the proprietary Avivagen OxC-BetaTM additive are now available in the United States on Amazon and Drtobias.com. “We’ve been working closely with the Avivagen team to launch the first Dr Tobias branded product into …Read More

Avivagen Announces Update on Private Placement Process

Ottawa, ON /Business Wire/ January 20, 2020 / — Avivagen Inc. (TSXV:VIV) (“Avivagen” or the “Company”), a life sciences innovation company with a series of patent protected products that support and optimize human and animal health, is pleased to provide an update on the status of its previously announced non-brokered private placement (the “Offering”) of …Read More

Avivagen Inc. Commences Trading on the OTCQB® Venture Market in the U.S.

Ottawa, ON / Business Wire / January 08, 2020 / – Avivagen Inc. (TSXV:VIV, OTCQB: VIVXF) (“Avivagen”), a life sciences innovation company with a series of patent protected products that support and optimize human and animal health, is pleased to announce that it has qualified to trade its common shares in the United States on …Read More

Avivagen Announces Closing of $1.25 Million Private Placement

Ottawa, ON /Business Wire/ January 3, 2020 / — Avivagen Inc. (TSXV:VIV) (“Avivagen” or the “Company”), a life sciences innovation company with a series of patent protected products that support and optimize human and animal health, is pleased to announce the successful completion of a non-brokered private placement (the “Offering”), issuing 2,500,000 units (the “Units”) …Read More

Avivagen Inc. Announces Results for Fiscal Year Ending October 31, 2019

Ottawa, ON /Business Wire/ December 19, 2019 / — Avivagen Inc. (TSXV:VIV) (“Avivagen” or the “Company”) today reported its audited financial results for the year ended October 31, 2019. Unless otherwise noted, all figures are in Canadian currency. The Company’s audited year end Financial Statements and its Management’s Discussion and Analysis for the year ended …Read More